Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CVS Health Corp (NYSE:CVS)

83.54
Delayed Data
As of Jan 18
 -0.38 / -0.45%
Today’s Change
69.30
Today|||52-Week Range
106.67
+5.87%
Year-to-Date
CVS Regular Dividend: CVS will begin trading ex-dividend on 01/20/17 with a $0.50 dividend payable to shareholders of record as of 01/24/17.
Target Slides 6% on Disappointing Holiday Sales
Jan 18 / Zacks.com - Paid Partner Content
Examining Volkswagen and Fiat Chrysler's Emissions Cheating Scandals
Jan 13 / Zacks.com - Paid Partner Content
Hills Bank & Trust Co Buys CVS Health Corp, Alliance Data Systems Corp, Twenty-First ...
Jan 18 / GuruFocus News - Paid Partner Content
Hate Checking Your Portfolio? Try These 3 Stocks
Jan 13 / MotleyFool.com - Paid Partner Content
3 Reasons CVS Health Corporation Stock Could Rise
Jan 18 / MotleyFool.com - Paid Partner Content
Fifth Street Asset Management, Cray, CVS Health, Mylan and Impax Laboratories highlig...
Jan 13 / Zacks.com - Paid Partner Content
7 Stocks With Strong Yields
Jan 17 / GuruFocus News - Paid Partner Content
Stock Market Roundup, Jan. 12: AMZN Jobs, FCAU Cheating, AKS & X Tank
Jan 12 / Zacks.com - Paid Partner Content
Better Buy: CVS Health Corporation vs. Kroger
Jan 17 / MotleyFool.com - Paid Partner Content
Mylan Crushed by Trump, Cigna and CVS -- All In Two Days
Jan 12 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close83.92
Today’s open84.49
Day’s range83.20 - 84.72
Volume5,263,133
Average volume (3 months)7,764,939
Market cap$89.5B
Dividend yield2.39%
Data as of 4:03pm ET, 01/18/2017

Growth & Valuation

Earnings growth (last year)+16.72%
Earnings growth (this year)+12.54%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+9.99%
P/E ratio17.9
Price/Sales0.72
Price/Book2.48

Competitors

 Today’s
change
Today’s
% change
WBAWalgreen-0.10-0.12%
ESRXExpress Scripts Hold...-0.49-0.67%
RADRite Aid Corp-0.02-0.23%
DPLODiplomat Pharmacy In...+0.17+1.24%
Data as of 4:14pm ET, 01/18/2017

Financials

Next reporting dateFebruary 9, 2017
EPS forecast (this quarter)$1.67
Annual revenue (last year)$153.3B
Annual profit (last year)$5.2B
Net profit margin3.39%

Profile

Sector
Retail Trade
Industry
Drugstore Chains
President, CEO &
Non-Independent Director
Larry J. Merlo
Chief Financial Officer &
Executive Vice President
David M. Denton
Corporate headquarters
Woonsocket, Rhode Island

Forecasts


Search for Jobs